Biological Evaluation of 3-Aminoisoquinolin-1(2H)-one Derivatives as Potential Anticancer Agents
Тип публікації :
Стаття
Дата випуску :
2021
Автор(и) :
Potikha, Lyudmyla
Brovarets, Volodymyr
Zhirnov, Victor
Мова основного тексту :
Англійська
eKNUTSHIR URL :
Том :
9
Випуск :
2
ISSN :
2312-3222
Початкова сторінка :
52
Кінцева сторінка :
63
Цитування :
[APA 7] Potikha, L., Brovarets, V., & Zhirnov, V. (2021). Biological Evaluation of 3-Aminoisoquinolin-1(2H)-one Derivatives as Potential Anticancer Agents. French-Ukrainian Journal of Chemistry, 9(2), 52–63. https://doi.org/10.17721/fujcV9I2P52-63
[ДСТУ] Potikha L., Brovarets V., Zhirnov V. Biological Evaluation of 3-Aminoisoquinolin-1(2H)-one Derivatives as Potential Anticancer Agents. French-Ukrainian Journal of Chemistry. 2021. Vol. 9, no. 2. P. 52—63. DOI: 10.17721/fujcV9I2P52-63 (date of access: 25.07.2026).
Anticancer activity of a series of 3-(hetaryl/aryl)amino substituted isoquinolin-1(2H)-ones has been studied within the international scientific program “NCI-60 Human Tumor Cell Lines Screen”. Screening was performed in vitro on 60 cell lines of lungs, kidneys, CNS, ovaries, prostate, and breast cancer, epithelial cancer, leukemia, and melanoma. The most effective compounds were those with thiazolyl or pyrazolyl substituent at 3-amino group and had no substituents at C(4) of the isoquinoline cycle. We identified a new lead compound, 3-(1,3-thiazol-2-ylamino)isoquinolin-1(2H)-one 12, which effectively prevents tumor cell growth (average lg GI50 = -5.18, lg TGI = -4.1, lg LC50 > -4.0) with good selectivity.
Файл(и) :![Ескіз]()
Вантажиться...
Формат :
Adobe PDF
Розмір :
757.1 KB
Контрольна сума :
(MD5):3d7ff2380a3601e0b74ec10d9dac14e4
Якщо не вказано інше, ця робота розповсюджується на умовах ліцензії Creative Commons Attribution 4.0 International